Unknown

Dataset Information

0

The Role of miRNA for the Treatment of MGMT Unmethylated Glioblastoma Multiforme.


ABSTRACT: Glioblastoma multiforme (GBM) is the most common high-grade intracranial tumor in adults. It is characterized by uncontrolled proliferation, diffuse infiltration due to high invasive and migratory capacities, as well as intense resistance to chemo- and radiotherapy. With a five-year survival of less than 3% and an average survival rate of 12 months after diagnosis, GBM has become a focus of current research to urgently develop new therapeutic approaches in order to prolong survival of GBM patients. The methylation status of the promoter region of the O6-methylguanine-DNA methyltransferase (MGMT) is nowadays routinely analyzed since a methylated promoter region is beneficial for an effective response to temozolomide-based chemotherapy. Furthermore, several miRNAs were identified regulating MGMT expression, apart from promoter methylation, by degrading MGMT mRNA before protein translation. These miRNAs could be a promising innovative treatment approach to enhance Temozolomide (TMZ) sensitivity in MGMT unmethylated patients and to increase progression-free survival as well as long-term survival. In this review, the relevant miRNAs are systematically reviewed.

SUBMITTER: Kirstein A 

PROVIDER: S-EPMC7281574 | biostudies-literature | 2020 Apr

REPOSITORIES: biostudies-literature

altmetric image

Publications

The Role of miRNA for the Treatment of MGMT Unmethylated Glioblastoma Multiforme.

Kirstein Anna A   Schmid Thomas E TE   Combs Stephanie E SE  

Cancers 20200428 5


Glioblastoma multiforme (GBM) is the most common high-grade intracranial tumor in adults. It is characterized by uncontrolled proliferation, diffuse infiltration due to high invasive and migratory capacities, as well as intense resistance to chemo- and radiotherapy. With a five-year survival of less than 3% and an average survival rate of 12 months after diagnosis, GBM has become a focus of current research to urgently develop new therapeutic approaches in order to prolong survival of GBM patien  ...[more]

Similar Datasets

| S-EPMC5356284 | biostudies-literature
| S-EPMC5692444 | biostudies-literature
| S-EPMC6888814 | biostudies-literature
| S-EPMC10243985 | biostudies-literature
| S-EPMC6549560 | biostudies-literature
| S-EPMC7596890 | biostudies-literature
| S-EPMC3890604 | biostudies-literature
| S-EPMC4706947 | biostudies-literature
| S-EPMC6444190 | biostudies-literature
| S-EPMC4237465 | biostudies-literature